Spots Global Cancer Trial Database for Hemostatic Procedure After Biopsy of the Cervix
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Hemostatic Procedure After Biopsy of the Cervix
Official Title: Is a Hemostatic Procedure Required After Biopsy of the Cervix Uteri in Women Undergoing Colposcopy for Cervical Dysplasia? A Multicenter Randomized Non-inferiority Trial
Study ID: NCT02486471
Conditions
Study Description
Brief Summary: Cytological abnormalities of the Cervix uteri need to be clarified by colposcopy biopsy. To avoid bleeding after biopsy, monsel´s paste is a common used Agent. In a randomized clinical Trial the use of monsel´s paste after biopsy will be compared to no Intervention. The Primary outcome of the study is blood loss, secondary outcomes are pain, satisfaction of the patient and influence of Independent factors such as Age and Body mass index.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Zydolab - Institute of Cytology and Immune Cytochemistry, Dortmund, NRW, Germany
Department of Obstetrics and Gynecology of the Ruhr University Bochum, Herne, NRW, Germany
Contact Details
Name: Ziad Hilal, M. D.
Affiliation: Zydolab - Institute of Cytology and Immune Cytochemistry
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
